Vicks VapoRub Ointment
Natural health product licensed in Canada
- Other names
- Vicks VapoRub Advanced Plus, Vicks VapoRub Children's
- Licence holder
- Procter & Gamble Inc.
- NPN or DIN-HM
- 01935747
- Status
- Active licence
- Licence date
- 25 July 2008
- Revision date
- 14 May 2025
- Form
- Onguent
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Essence de térébenthine, Myristica Oil, Thuja occidentalis, Pétrolatum, Acétate de carboxamidoéthyle de menthane, Paraffin, Thymol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Effective cold relief. For relief of nasal congestion, coughs, and muscle aches and pains due to colds. Temporarily relieves minor aches & pains of muscles and joints.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 01935747
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.